FBInvestor
Stocks / Regeneron Pharmaceuticals
Institutional Ownership

Regeneron Pharmaceuticals

CUSIP 75886F907COMREGNQ1 2026

No short-interest data on record yet

FINRA publishes consolidated short interest twice a month. Coverage expands as the bi-monthly feed runs.